Related Experiment Video
Updated: May 3, 2026

Author Spotlight: Self-Assessment Protocol for Predicting Psoriatic Arthritis in Psoriasis Patients
Published on: March 1, 2024
Psoriasis: the visible killer
Tiago Torres1, Nuno Bettencourt2
1Department of Dermatology, Centro Hospitalar do Porto, Porto, Portugal; Unit for Multidisciplinary Investigation in Biomedicine, Instituto de Ciências Biomédicas Abel Salazar - Universidade do Porto, Porto, Portugal.
Insights
Severe psoriasis patients face increased cardiovascular risks due to chronic inflammation. Early detection and multidisciplinary management of psoriasis and its comorbidities are crucial for preventing heart attacks and strokes.
Area of Science:
- Dermatology
- Cardiology
- Immunology
Background:
- Psoriasis is a chronic inflammatory skin condition linked to significant comorbidities.
- Severe psoriasis is associated with increased mortality from cardiovascular diseases like myocardial infarction and stroke.
- Patients with psoriasis exhibit a higher prevalence of traditional cardiovascular risk factors.
Purpose of the Study:
- To emphasize the link between psoriasis's chronic inflammation and cardiovascular disease (CVD) risk.
- To highlight the necessity of managing psoriasis comorbidities and CVD.
- To advocate for effective psoriasis treatment to reduce systemic inflammation.
Main Methods:
- Review of existing literature on psoriasis, comorbidities, and cardiovascular outcomes.
- Analysis of the role of chronic inflammation in psoriasis-related CVD.
- Discussion of multidisciplinary care strategies for severe psoriasis patients.
Main Results:
- Chronic inflammation in psoriasis may be an independent risk factor for CVD.
- Psoriasis patients have elevated rates of diabetes, hypertension, dyslipidemia, and obesity.
- Effective psoriasis treatment can mitigate systemic inflammation and potentially lower CVD risk.
Conclusions:
- Early identification and treatment of psoriasis comorbidities and CVD are essential.
- A multidisciplinary approach is vital for optimizing the care of severe psoriasis patients.
- Managing systemic inflammation in psoriasis is key to preventing cardiovascular events.
Abstract:
Psoriasis is a common chronic inflammatory disease associated with serious comorbidities. In recent years, increased mortality due to cardiovascular disease (myocardial infarction and stroke) has been documented in patients with severe psoriasis. Patients with psoriasis have a higher prevalence of traditional cardiovascular risk factors such as diabetes, hypertension, dyslipidemia and obesity, but it has been suggested that the chronic inflammatory nature of psoriasis is also a contributing and potentially an independent risk factor for the development of cardiovascular disease. The authors highlight the need for early identification and treatment of psoriasis-related comorbidities and cardiovascular disease, as well as effective treatment of psoriasis, in order to reduce the underlying systemic inflammation, and also the importance of a multidisciplinary approach of severe psoriasis patients to optimize the diagnosis, monitoring and treatment of various comorbidities, so as to prevent cardiovascular events.
Related Concept Videos
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Staphylococcal Skin Infections
Acne Infection
Changes in Skin Color: Clinical Perspectives
Albinism
Albinism is a genetic disorder that affects (completely or partially) the coloring of skin, hair, and eyes. The defect is primarily...
Multiple Sclerosis l: Introduction

